Medikra is focused on addressing unmet medical needs in metabolic disease, women's health, chronic inflammation, and oncology—areas where current therapies may face limitations in safety, efficacy, or cultural acceptance. Development programs are pursued across pharmaceutical and nutraceutical pathways, and aligned with global regulatory frameworks including the FDA, EFSA, and regional Asian authorities.